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EDITORIAL
Light from DARCness
The recruitment of leukocytes during host defense cytes with high affinity for the C-X-C chemokines in-
and inflammation is a complex process involving the terleukin-8 (IL-8) and melanoma growth stimulatory ac-
coordinated interactions of leukocyte adhesion mole- tivity (MGSA) and for the C-C chemokines RANTES
cules and chemoattractants [1–4]. Included among the and monocyte chemotactic peptide-1 (MCP-1). Detailed
latter chemoattractant molecules are the chemokines, a analysis of this novel chemokine receptor revealed that
superfamily of small (,8–13 kD) secreted cytokines it is identical to DARC [6].
[3, 4]. The characterization of key molecular determi- The immunohistochemical demonstration of DARC
nants of leukocyte trafficking in renal disease has already expression on endothelial cells lining post-capillary ven-
identified a range of attractive new therapeutic targets in ules, but not endothelium of most other vessels, shed new
glomerulonephritis, tubulointerstitial nephritis, ischemic light on the biology of DARC [6]. Endothelial DARC
acute renal failure and allograft rejection [2, 4]. Several expression is observed even in individuals with the Duffy
agents that block chemokine and adhesion molecule ex- antigen-negative erythroid phenotype suggesting cell-
pression or function have already been shown to confer type specific regulation of gene transcription. Curiously
impressive protection in experimental models of renal DARC expression has also been described under normal
inflammation [2, 4]. It is clear, however, that many impor- conditions by cerebellar Purkinje cells [6]. Up-regulation
tant players have yet to be defined and that, in an envi- of DARC expression has been reported on glomerular
ronment where there is frequently overlap of function, endothelium, collecting duct cells and interstitial cells in
the hierarchy of mediators has yet to be fully established. children with HIV-associated nephropathy, HIV-associ-
In this issue of Kidney International Segerer et al re- ated hemolytic uremic syndrome and classic hemolytic
port important new data on the expression of an intri- uremic syndrome [7], and on the endothelium of large
guing chemokine receptor identified relatively recently, vessels in temporal arteritis and thrombophlebitis [6].
namely Duffy antigen receptor for chemokines (DARC) When coupled with the ability of DARC to bind C-C
[5]. The history of DARC is a glowing tribute to investi- and C-X-C cytokines, these observations raise the possi-
gators exploring remarkably diverse topics [reviewed ex- bility of an immunomodulatory role for DARC in in-
tensively in 6]. Following the initial identification of che- flammatory diseases. Against this background, in this
mokines and adhesion molecules as pivotal regulators issue Segerer et al report a marked increase in DARC
of leukocyte recruitment during host defense and in- positive venules in the renal interstitium during trans-
flammation, it became apparent that many microorgan- plant rejection and crescentic glomerulonephritis, in as-
isms (such as HIV, rhinovirus) infect host cells by sociation with an infiltration of CCR5 positive leukocytes
usurping the function of chemokine receptors and adhe- [5]. DARC was not expressed in the glomerulus, even
sion molecules [1–4]. With respect to DARC, the order in crescentic glomerulonephritis [5]. They propose that
of discovery was reversed [6]. DARC was originally de- DARC may serve to present chemokines to CCR5 posi-
scribed as the Duffy antigen, a glycoprotein blood group tive cells in this context and thereby promote leukocyte
antigen expressed on the surface of erythrocytes that is recruitment into the tubulointerstitium. Their contention
a receptor for invasion of these cells by the malarial is further supported by the following observations: (a)
parasite Plasmodium vivax. Erythrocytes from individu- the concept of chemokine presentation to leukocytes is
als of the Duffy antigen-negative phenotype are resistant a well-validated paradigm in chemokine research; (b)
to infection by P. vivax merozoites and P. vivax infection post-capillary venules are a major site for leukocyte ex-
is virtually completely absent from West Africa where travasation in host defense and disease; and (c) DARC
greater than 95% of the population are Duffy antigen- null mice show impaired neutrophil migration in lipo-
negative, unlike most other tropical and subtropical re- polysaccharide and thioglycolate induced models of peri-
gions where this infection is prevalent [6]. Subsequently, tonitis in vivo [1–4, 8].
a novel chemokine receptor was identified on erythro- Importantly, however, Segerer and colleagues do not
dismiss a possible anti-inflammatory role whereby DARC
could serve as a “sink” for removal of chemokines duringKey words: Transplant rejection, crescentic glomerulonephritis, Duffy
antigen receptor for chemokines, DARC, chemokines, leukocytes. inflammation [5]. Indeed, several lines of evidence sup-
port an anti-inflammatory role for DARC: (a) IL-8 isÓ 2000 by the International Society of Nephrology
1816
Editorial 1817
not chemotactic for polymorphonuclear neutrophils once and should shed further light on the role of DARC in
health and disease.bound to the erythrocyte surface, thereby arguing against
a “presenting” function; (b) DARC transfectants internal-
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DARC positive erythrocytes do not; and (c) DARC-
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plasmic loop characteristic of G-protein-coupled seven
transmembrane spanning receptors and the ability to REFERENCES
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